[14C]-6-tert-butyl-2-(2-(hydroxymethyl)-3-(1-methyl-5-(5-(morpholine-4-carbonyl)pyridin-2-ylamino)-6-oxo-1,6-dihydropyridin-3-yl)phenyl)-3,4-dihydroisoquinolin-1(2H)-one

ID: ALA4098685

PubChem CID: 137659731

Max Phase: Preclinical

Molecular Formula: C36H39N5O5

Molecular Weight: 621.74

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2cccc(N3CCc4cc(C(C)(C)C)ccc4C3=O)c2[14CH2]O)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O

Standard InChI:  InChI=1S/C36H39N5O5/c1-36(2,3)26-9-10-28-23(18-26)12-13-41(34(28)44)31-7-5-6-27(29(31)22-42)25-19-30(35(45)39(4)21-25)38-32-11-8-24(20-37-32)33(43)40-14-16-46-17-15-40/h5-11,18-21,42H,12-17,22H2,1-4H3,(H,37,38)/i22+2

Standard InChI Key:  HCJJXHLWABHYMG-FSEIIBCTSA-N

Molfile:  

     RDKit          2D

 46 51  0  0  0  0  0  0  0  0999 V2000
    5.6902  -20.9038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6890  -21.7311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4038  -22.1440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1202  -21.7306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1174  -20.9002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4020  -20.4910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8278  -20.4851    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5436  -20.8971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5397  -19.2481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8226  -19.6614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2556  -19.6601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2514  -20.4854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9629  -20.8997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6791  -20.4899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6792  -19.6615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9670  -19.2508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5454  -21.7220    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3995  -19.6660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1127  -19.2514    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9763  -20.4916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9781  -19.6656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2676  -19.2534    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5509  -19.6626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5490  -20.4885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2641  -20.9053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2706  -18.4284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8378  -19.2476    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8333  -20.8988    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8306  -21.7238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1147  -22.1291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1117  -22.9533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8254  -23.3689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5435  -22.9543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5430  -22.1314    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3936  -19.2488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1081  -19.6611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3934  -18.4238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1040  -18.8288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8239  -24.1939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1086  -24.6051    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5375  -24.6077    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5385  -25.4294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2481  -25.8431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9657  -25.4354    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9693  -24.6094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2551  -24.1912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  7 10  1  0
  8 12  1  0
 11  9  1  0
  9 10  1  0
  5  7  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  8 17  2  0
  6 18  1  0
 18 19  1  0
 20 21  2  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
  1 20  1  0
 22 26  1  0
 23 27  2  0
 24 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 15 35  1  0
 35 36  1  0
 35 37  1  0
 35 38  1  0
 32 39  1  0
 39 40  2  0
 39 41  1  0
 41 42  1  0
 41 46  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
M  ISO  1  18  14
M  END

Associated Targets(Human)

Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 621.74Molecular Weight (Monoisotopic): 621.2951AlogP: 4.66#Rotatable Bonds: 6
Polar Surface Area: 117.00Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.38CX Basic pKa: 3.94CX LogP: 3.17CX LogD: 3.17
Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.32Np Likeness Score: -0.99

References

1. Lou Y, Lopez F, Jiang Y, Han X, Brotherton C, Billedeau R, Gabriel S, Gleason S, Goldstein DM, Hilgenkamp R, Kocer B, Orzechowski L, Tan J, Wovkulich P, Wen B, Fry D, Di Lello P, Chen L, Zhang FJ, Fretland J, Nangia A, Yang T, Owens TD..  (2017)  Mitigation of reactive metabolite formation for a series of 3-amino-2-pyridone inhibitors of Bruton's tyrosine kinase (BTK).,  27  (3): [PMID:28025004] [10.1016/j.bmcl.2016.11.092]

Source